Join
Live feed
·
INSIDERFilingvia Quantisnow
Rubius Therapeutics Inc. logo

SEC Form 4: Epstein David R bought $43,329 worth of shares (30,000 units at $1.44), increasing direct ownership by 0.64% to 4,720,012 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RUBY (Rubius Therapeutics Inc.) and more on Quantisnow.